{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:43:55Z","timestamp":1786718635073,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Res Pharma Sci"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/1735-5362.220965","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T06:05:41Z","timestamp":1513317941000},"page":"30","source":"Crossref","is-referenced-by-count":13,"title":["Anti-tuberculosis and cytotoxic evaluation of the seaweed Sargassum boveanum"],"prefix":"10.4103","volume":"13","author":[{"given":"Afsaneh","family":"Yegdaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajihe","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Zafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-5362.220965-1","first-page":"800","volume-title":"Fate of Mycobacterium tuberculosis within murine dendritic cells.Infect Immun","author":"Bodnar","year":"2001","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-2","first-page":"363","volume-title":"Tuberculosis: a search for novel therapy starting with natural products.Med Res Rev","author":"Mitscher","year":"1998","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-3","unstructured":"Adhikari PR. Probabilistic Modelling of Multiresolution Biological Data. Department of information and computer science, Aalto university publication series doctoral dissertations 157\/2014, Finland. 2014."},{"key":"key-10.4103\/1735-5362.220965-4","first-page":"g1338","volume-title":"Global cancer prevalence is growing at \u201calarming pace,\u201d says WHO.BMJ","author":"Gulland","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-5","first-page":"235","volume-title":"Marine organisms and other novel natural sources of new cancer drugs.Ann Oncol","author":"Schwartsmann","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-6","first-page":"221","volume-title":"Marine organisms as a source of new anticancer agents.Lancet Oncol","author":"Schwartsmann","year":"2001","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-7","first-page":"237","volume-title":"Marine natural products.Nat Prod Rep","author":"Blunt","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-8","first-page":"1355","volume-title":"3-oxoabolene and 1-oxocurcuphenol, aromatic bisabolanes from the sponge Myrmekioderma sp.Nat prod Commun","author":"Yegdaneh","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-9","first-page":"410","volume-title":"Bioactive compounds from marine actinomycetes.Indian J Microbiol","author":"Solanki","year":"2008","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-10","first-page":"1","volume-title":"Antitumor compounds from tunicates.Med Res Rev","author":"Rinehart","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-11","first-page":"171","volume-title":"Antimicrobial activities of the extracts of marine algae from the coast of Urla (Izmir, Turkey).Turk J Biol","author":"T\u00dcney","year":"2006","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-12","first-page":"311","volume-title":"Chemical constituents and biological activities of two Iranian Cystoseira species.Res Pharm Sci","author":"Yegdaneh","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-13","first-page":"95","volume-title":"Bioactive steroids from the brown alga Sargassum carpophyllum.J Asian Nat Prod Res","author":"Tang","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-14","first-page":"243","volume-title":"Phytochemical and biological evaluation of some Sargassum species from Persian Gulf.Res Pharm Sci","author":"Mehdinezhad","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-15","first-page":"113","volume-title":"Screening for antimalarial and acetylcholinesterase inhibitory activities of some Iranian seaweeds.Res pharm sci","author":"Ghannadi","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-16","first-page":"146","volume-title":"The checklist of green algae of the Iranian coastal lines of the Persian Gulf and Gulf of Oman.Iran J Bot","author":"Sohrabipour","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-17","doi-asserted-by":"crossref","unstructured":"Kupchan SM, Tsou G. Tumor inhibitors. structure and partial synthesis of fabacein. J Org Chem. 1973;38(5):1055-1056.","DOI":"10.1021\/jo00945a044"},{"key":"key-10.4103\/1735-5362.220965-18","first-page":"344","volume-title":"Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.Antimicrob Agents Chemother","author":"Collins","year":"1998","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-19","first-page":"1348","volume-title":"A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase.Antimicrob Agents Chemother","author":"Cooksey","year":"1993","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-20","first-page":"1004","volume-title":"Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.Antimicrob Agents Chemother","author":"Collins","year":"1997","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-21","first-page":"1","volume-title":"Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation.J Nanopart Res","author":"Akbari","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-22","first-page":"1217","volume-title":"Qualitative and quantitative drug-susceptibility tests in mycobacteriology.Am Rev Respir Dis","author":"Heifets","year":"1988","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-23","first-page":"3682","volume-title":"Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter.Antimicrob Agents Chemother","author":"Changsen","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-24","doi-asserted-by":"crossref","unstructured":"Mary JS, Vinotha P, Pradeep AM. Screening for in vitro cytotoxic activity of seaweed, Sargassum sp. against Hep-2 and MCF-7 cancer cell lines. Asian Pac J Cancer Prev. 2012;13(12):6073-6076.","DOI":"10.7314\/APJCP.2012.13.12.6073"},{"key":"key-10.4103\/1735-5362.220965-25","first-page":"108","volume-title":"Evaluation of cytotoxic activity of Sargassum vulgare From the Lebanese Coast against Jurkat cancer cell line.J App Pharm Sci","author":"Tannourya","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-26","first-page":"31","volume-title":"Cytotoxic activity of some marine brown algae against cancer cell lines.Biol Res","author":"Khanavi","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-27","first-page":"95","volume-title":"Evaluation of plants used for antimalarial treatment by the Maasai of Kenya.J Ethnopharmacol","author":"Koch","year":"2005","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-28","first-page":"207","volume-title":"Cytotoxic activity of crude extract and fractions from Sargassum siliquosum (JG Agardh) and other seaweeds against selected human cancer cell lines.Int J Biosci (IJB)","author":"Tantengco","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-29","first-page":"1607","volume-title":"Inhibition of a Mycobacterium tuberculosis \u03b2-ketoacyl ACP synthase by isoniazid.Science","author":"Mdluli","year":"1998","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-30","first-page":"545","volume-title":"The treatment of tuberculosis: current status and future prospects.Expert opin Investig Drugs","author":"Snell","year":"1998","journal-title":""},{"key":"key-10.4103\/1735-5362.220965-31","first-page":"52","volume-title":"Tuberculosis: a tough adversary-With the tools for a renewed battle in place, development of new weapons to combat the ancient plague should proceed at a rapid pace.Chem Eng News","author":"Rouhi","year":"1999","journal-title":""}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:44Z","timestamp":1786714664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-5362.220965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"alternative-id":["220965"],"URL":"https:\/\/doi.org\/10.4103\/1735-5362.220965","relation":{},"ISSN":["1735-5362"],"issn-type":[{"value":"1735-5362","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}